Chanticleer Holdings Aktie
WKN DE: A2P2NP / ISIN: US83548R1059
01.04.2025 14:05:27
|
Sonnet BioTherapeutics Names Raghu Rao Interim CEO As Founder Passes
(RTTNews) - Sonnet BioTherapeutics Holdings, Inc. (SONN), Tuesday said it has appointed one of its directors Raghu Rao as interim chief executive officer after the company's founder and CEO Pankaj Mohan passed away.
Stephen McAndrew, Sonnet's current chief business officer has been promoted to president and chief business officer.
The company noted that it plans to launch a CEO search.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Chanticleer Holdings Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |